成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 1026201-45-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1026201-45-5
Chemical Structure| 1026201-45-5
Structure of 1026201-45-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1026201-45-5 ]

Related Doc. of [ 1026201-45-5 ]

Alternatived Products of [ 1026201-45-5 ]
Product Citations

Product Details of [ 1026201-45-5 ]

CAS No. :1026201-45-5 MDL No. :MFCD12195903
Formula : C8H5BrN2O2 Boiling Point : No data available
Linear Structure Formula :- InChI Key :OREYKECANVXONJ-UHFFFAOYSA-N
M.W : 241.04 Pubchem ID :46942157
Synonyms :

Calculated chemistry of [ 1026201-45-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.85
TPSA : 54.6 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.13 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 2.31
Log Po/w (WLOGP) : 1.79
Log Po/w (MLOGP) : 1.05
Log Po/w (SILICOS-IT) : 0.96
Consensus Log Po/w : 1.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.24
Solubility : 0.14 mg/ml ; 0.000581 mol/l
Class : Soluble
Log S (Ali) : -3.09
Solubility : 0.194 mg/ml ; 0.000804 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.32
Solubility : 1.16 mg/ml ; 0.00481 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 1026201-45-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1026201-45-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1026201-45-5 ]

[ 1026201-45-5 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1038393-19-9 ]
  • [ 1026201-45-5 ]
YieldReaction ConditionsOperation in experiment
88% Intermediate 37 (2.02 g, 7.4 mmol) was dissolved in a mixture of dioxane/ H2O (16 ml/4 ml) and the mixture was cooled on an ice-bath. LiOH (355 mg, 14.8 mmol) was added and the resulting mixture was stirred for 20 h at r.t. The volatiles were evaporated under reduced pressure. The mixture was cooled using an ice-bath, and was acidified with an aq. IN HCl solution until pH 4. The precipitate was filtered off, washed with cold water (10 ml), and dried in vacuo. Yield 1.5 g of intermediate 39 (88 %).
Intermediate C3: 8-Bromoimidazori,2-alphalpyridine-2-carboxylic acidTo a solution of 2-amino-3-bromopyridine (7.4 g, 0.0428 mol) in dimethoxyethane (70 mL) under N2, ethylbromopyruvate (9.28 g, 0.0428 mol) was added, and the mixture stirred at RT for 18 hours. The resulting solids were filtered and washed with Et2O, then re-suspended in absolute EtOH (40 mL) and refluxed for 2 hours. The reaction was concentrated to remove EtOH, diluted with K2CO3(aq.) and extracted with DCM (2 x 100 mL). The DCM extracts were dried over Na2SO4, filtered and concentrated to give a foam (9.2 g). The EPO <DP n="53"/>foam was dissolved in THF (230 rnL) and treated with IN NaOH (170 mL, 0.170 mol) at 40C for 2 hours. The reaction was cooled to RT, diluted with IN HCl (170 mL, 0.170 mol) and concentrated to remove the THF (pH of mixture = 3.0). The mixture was cooled to 0C, aged for 30 minutes and filtered. The cake was washed with H2O (40 mL) and dried under vacuum to give 7.94 g. LRMS (M+H)+ 241.
  • 2
  • [ 1026201-45-5 ]
  • [ 1117-97-1 ]
  • [ 1232039-30-3 ]
YieldReaction ConditionsOperation in experiment
57% A suspension of intermediate 39 (322 mg, 1.34 mmol) and carbonyldiimidazole (238 mg, 1.47 mmol) in THF (11 ml) was stirred at r.t. for 2 h. DIPEA (0.233 ml, 1.34 mmol) was added and the resulting mixture was stirred for 30 min. at r.t. Then DMF (2 ml) was added to the suspension and the mixture was stirred for 60 h at r.t. The r.m. was cooled to 0 0C and O,N-dimethyl-hydroxylamine (143 mg, 1.47 mmol) was added. The mixture was stirred for 20 h at r.t. The solvents were evaporated under reduced pressure. The residue was dissolved in DCM and washed 3 times with H2O. The organic layer was dried (MgSO4), filtered and evaporated under reduced pressure. The residue was purified via flash column chromatography over silicagel (eluent: DCM/MeOH(NH3) from 100/0 to 99/1). The product fractions were collected and the solvent was evaporated in vacuo. Yield: 216 mg of intermediate 42 (57 %).
  • 3
  • [ 1026201-45-5 ]
  • [ 1232039-26-7 ]
YieldReaction ConditionsOperation in experiment
99% With thionyl chloride;Reflux; Cooling with ice; SOCl2 (15 ml, 206 mmol) was added slowly to intermediate 39 (1.6 g, 6.6 mmol) while cooling on ice. The resulting solution was heated to reflux temperature for 4 h, and was then cooled to r.t. and concentrated in vacuo. The residue was triturated with DIPE and finally the product was dried. Yield: 1.7 g of intermediate 40 (99 %).
Recommend Products
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1026201-45-5 ]

Bromides

Chemical Structure| 749849-14-7

[ 749849-14-7 ]

6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 1019021-93-2

[ 1019021-93-2 ]

7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid

Similarity: 0.78

Chemical Structure| 944896-42-8

[ 944896-42-8 ]

6-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 143982-54-1

[ 143982-54-1 ]

Ethyl 3-bromoimidazo[1,2-a]pyridine-2-carboxylate

Similarity: 0.75

Chemical Structure| 1260784-00-6

[ 1260784-00-6 ]

6-Bromo-8-fluoroimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.75

Carboxylic Acids

Chemical Structure| 749849-14-7

[ 749849-14-7 ]

6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 64951-08-2

[ 64951-08-2 ]

Imidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 88751-06-8

[ 88751-06-8 ]

5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 1019021-93-2

[ 1019021-93-2 ]

7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid

Similarity: 0.78

Chemical Structure| 80353-93-1

[ 80353-93-1 ]

6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.78

Related Parent Nucleus of
[ 1026201-45-5 ]

Other Aromatic Heterocycles

Chemical Structure| 749849-14-7

[ 749849-14-7 ]

6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 64951-08-2

[ 64951-08-2 ]

Imidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 88751-06-8

[ 88751-06-8 ]

5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid

Similarity: 0.83

Chemical Structure| 158980-21-3

[ 158980-21-3 ]

Ethyl 6-aminoimidazo[1,2-a]pyridine-2-carboxylate

Similarity: 0.78

Chemical Structure| 1019021-93-2

[ 1019021-93-2 ]

7-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid

Similarity: 0.78

; ;